Page 8 - Randomized Controlled Trials News Today

Benjamin Speich and colleagues investigate whether rates of trial completion and publication have increased over the past decade, the extent to which non-published trials can be identified in registries, and the association between reporting quality of protocols and premature discontinuation or non-publication of trials.

Max Performer is a pill that promises improved sexual performance. Read Max Performer Reviews to know why you should start taking it in 2023.

Catherine Staton and co-workers report on evidence about interventions against harmful alcohol use in low- and middle-income countries.

There is a lack of consensus in the definition of ‘relapse’ across randomized controlled trials of antipsychotic drugs.

Noelle Le Tourneau and co-workers study HIV outcomes in studies investigating reduced frequency of antiretroviral drug provision and clinical consultations.

Author summary Why was this study done? Sustained engagement and retention in HIV care is critical for optimal HIV treatment outcomes and reduced HIV transmission. For many people living with HIV, disengagement is inevitable during the long course of HIV treatment. It remains unclear which combination of reengagement strategies are most effective and under what conditions. What did the researchers do and find? Our systematic review identified 37 studies (6 randomized trials and 31 observat...

In a multi-arm randomized controlled trial, Cheng Wang and colleagues determine the effectiveness and cost of expanding syphilis self testing among men who have sex with men in China.

A new study on mobile mental health apps finds there is a lack of convincing evidence to support their effectiveness.

In a cross-sectional analysis, Shelley Vanderhout and colleagues assess the reporting of patient reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov.

A new review identified clinical studies evaluating coronavirus infections in the context of Echinacea administration and assessed preventive and therapy advantages against COVID-19.